ALLMedicine™ Disseminated Intravascular Coagulation Center

Dec 1st, 2021 - Key clinical point: Elevated serum amylase (ESA) was associated with adverse clinical outcomes and mortality in hospitalized patients with COVID-19. Major finding: Hyperamylasemia (amylase > upper limit of normal [ULN] of 115 U/L) was independentl.

Dec 1st, 2021 - Hematologic/Oncologic emergencies are rarely seen in the critical care transport environment but must be recognized and treated without delay. We report such a patient transported from a referring hospital to a tertiary care center by the LifePACT...

Nov 29th, 2021 - A proportion of people infected with SARS-CoV-2 develop moderate or severe COVID-19, with an increased risk of thromboembolic complications. The inflammatory response to SARS-CoV-2 infection can cause an acute-phase response and endothelial dysfun...

Nov 26th, 2021 - While severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection primarily causes inflammation in the respiratory system, there is growing evidence of extrapulmonary tissue damage mediated by the host innate immune system in children a...

Nov 23rd, 2021 - SARS-CoV-2 causes thrombotic microangiopathy (TMA) through the activation of an alternative and lectin complement pathway. TMA is one of the main reasons for acute kidney injury development in patients with COVID-19. In this study, we present 3 TM...

Sep 25th, 2017 - Maternal hemorrhage, defined as a cumulative blood loss of greater than or equal to 1,000 mL or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours after the birth process, remains the leading cause of maternal mortality wor...

Sep 21st, 2011 - The diagnosis and treatment of disseminated intravascular coagulation (DIC) remain extremely controversial. The Italian Society for Thrombosis and Haemostasis commissioned a project to develop clinical practice guidelines for the diagnosis and tre...

Feb 19th, 2009 - The diagnosis of disseminated intravascular coagulation (DIC) should encompass both clinical and laboratory information. The International Society for Thrombosis and Haemostasis (ISTH) DIC scoring system provides objective measurement of DIC. Wher...

Oct 29th, 2021 - The severe acute respiratory syndrome coronavirus 2, which causes the highly contagious coronavirus disease 2019 (COVID-19), has resulted in a global pandemic. The clinical spectrum of COVID-19 infection is broad, encompassing asymptomatic infecti...

Sep 29th, 2021 - Hemostatic, biomarker, and inflammatory changes are common in severe manifestations of coronavirus disease 2019 (COVID-19).Such factors, as well as the bedridden status and critical illness may constitute a prothrombotic milieu, predisposing to ve...

Sep 14th, 2021 - The ongoing COVID-19 pandemic affects millions of humans worldwide and has led to thousands of acute medical hospitalizations. There is evidence that hospitalized cases often suffer from an important infection-related coagulopathy and from elevate...

Aug 19th, 2021 - Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), is a highly contagious disease that appeared in Wuhan, Hubei province of China in December 2019. It has now spread to multiple countries through infected persons trav...

Jun 8th, 2021 - Coronavirus disease-19 (COVID-19 ), which is caused by SARS-CoV-2 infection, are apparently at high risk of venous thromboembolism (VTE), as a consequence of activation of the hemostatic system which, in the most severe cases, can also be associat...

Dec 1st, 2021 - Key clinical point: Elevated serum amylase (ESA) was associated with adverse clinical outcomes and mortality in hospitalized patients with COVID-19. Major finding: Hyperamylasemia (amylase > upper limit of normal [ULN] of 115 U/L) was independentl.

Oct 6th, 2021 - Rita Nanda, MD Immune checkpoint inhibitors can be of significant value in combatting recurrent and metastatic triple negative breast cancer (TNBC), Rita Nanda, MD, told physicians at the recent 14th Annual International Congress on the Future of...

Oct 6th, 2021 - Alice S. Mims, MD, medical oncologist, Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center—James, discusses her recommendations regarding holding therapy until molecular test results are r...

Oct 6th, 2021 - Alice Mims, MD The introduction of targeted therapies in acute myeloid leukemia (AML) has motivated research efforts dedicated to identifying biomarkers in the newly diagnosed and relapsed/refractory settings to better find optimal treatments for...

Apr 12th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Two scientific studies establishing a causal relationship between the AstraZeneca COVID-19 vaccine and severe thrombotic complications have now be...